Dr. Belgin Sever is an Associate Professor of Pharmaceutical Chemistry at Anadolu University, Faculty of Pharmacy. Her research focuses on developing novel drug candidates with anticancer, antimicrobial, antidiabetic, anti-HIV, and anti-ALS activities. She graduated as valedictorian from Anadolu University in 2013 and earned her MSc and PhD degrees in Pharmaceutical Chemistry in 2015 and 2019, respectively. She conducted postdoctoral research at Kumamoto University, Japan, supported by the Takeda Science Foundation International Fellowship Programme (2020–2021), TÜBİTAK 2219 International Postdoctoral Research Fellowship (2022–2023), and Japan Society for the Promotion of Science (JSPS) (2023–2025), focusing on anti-HIV, anticancer, and anti-ALS drug development, respectively. In 2022, she received the Young Woman Researcher Award at the Venus International Women Awards (VIWA) and an award from the Turkish Pharmacists’ Association – Academy of Pharmacy. In 2026, she received the L’Oréal–UNESCO For Women in Science Award for her research on developing novel therapeutic candidates for amyotrophic lateral sclerosis (ALS).